<p>The sequences of the four peptides selected to represent the V2 loop region for a variety of HIV-1 viruses. Peptide 1 represents the most polar V2 peptide, Peptide 2 the most commonly occurring peptide, Peptide 3 the most polar peptide of the most common length, and Peptide 4 the published consensus V2 peptide.</p><p>Diverse and representative peptide set.</p
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
<p>Name and sequence of Peptide Nucleic Acid (PNA) targeted against different sites of 5′UTR HIV-1.<...
BACKGROUND: The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction...
<p>Characteristics of peptides and peptide-pools for the five HIV protein regions.</p
(A) The top two panels show the peptides that were enriched by phage display immunoprecipitation for...
<p>The full lengths of each of the viral proteins containing 1st and/or 2nd tier CE are shown. The h...
The accurate identification of HIV-specific T cell responses is important for determining the relati...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
The antigenic diversity of human immunodeficiency virus type 1 (HIV-1) represents a significant chal...
AbstractThe HIV-1 gp120 V3 loop is a potent inducer of neutralizing antibodies for T cell line adapt...
<p>The x-axis corresponds to the V2 and V3 sequence, and the y-axis corresponds to the number of pre...
The rapid mutation of human immunodeficiency virus-type 1 (HIV-1) and the limited characterization o...
<p>*<sup>)</sup> Epitope IDs are written in the format 16484_POL_0.99_0.95_0.98, where the separated...
<p>A panel of 54 persons (from the Los Angeles area) with chronic HIV-1 infection and not receiving ...
Abstract Background The efficacy of the CTL component of a future HIV-1 vaccine will depend on the i...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
<p>Name and sequence of Peptide Nucleic Acid (PNA) targeted against different sites of 5′UTR HIV-1.<...
BACKGROUND: The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction...
<p>Characteristics of peptides and peptide-pools for the five HIV protein regions.</p
(A) The top two panels show the peptides that were enriched by phage display immunoprecipitation for...
<p>The full lengths of each of the viral proteins containing 1st and/or 2nd tier CE are shown. The h...
The accurate identification of HIV-specific T cell responses is important for determining the relati...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
The antigenic diversity of human immunodeficiency virus type 1 (HIV-1) represents a significant chal...
AbstractThe HIV-1 gp120 V3 loop is a potent inducer of neutralizing antibodies for T cell line adapt...
<p>The x-axis corresponds to the V2 and V3 sequence, and the y-axis corresponds to the number of pre...
The rapid mutation of human immunodeficiency virus-type 1 (HIV-1) and the limited characterization o...
<p>*<sup>)</sup> Epitope IDs are written in the format 16484_POL_0.99_0.95_0.98, where the separated...
<p>A panel of 54 persons (from the Los Angeles area) with chronic HIV-1 infection and not receiving ...
Abstract Background The efficacy of the CTL component of a future HIV-1 vaccine will depend on the i...
The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. ...
<p>Name and sequence of Peptide Nucleic Acid (PNA) targeted against different sites of 5′UTR HIV-1.<...
BACKGROUND: The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction...